Skip to main content
NCBI home page
Gut logoLink to Gut
. 1991 Feb;32(2):183–187. doi: 10.1136/gut.32.2.183

Morphometric studies in rectal biopsy specimens from patients with ulcerative colitis: effect of oral 5 amino salicylic acid and rectal prednisolone treatment.

A M Zaitoun 1, I Cobden 1, H al Mardini 1, C O Record 1
PMCID: PMC1378805  PMID: 1864539

Abstract

Morphometric measurements were performed on rectal biopsy specimens from 10 normal control subjects and 33 patients with a relapse of distal ulcerative colitis before and after treatment for four weeks in a double blind controlled trial with oral eudragit S coated 5 amino salicylic acid (n = 12) or rectal prednisolone enemas (n = 15). Measurements were assessed using a computer aided measuring system and a counting technique. When untreated patients were compared with the control group there were significant decreases in the area and height of the surface epithelium, in the area of crypt epithelium, and in the ratios of goblet cells to epithelial cells and of surface epithelium to lamina propria. The vascular and lamina propria areas and the number of intraepithelial polymorphs were increased. Treatment with 5 amino salicylic acid and corticosteroids resulted in similar morphological improvements: there was an increase in the area and height of the surface epithelium and the ratios of surface epithelium to lamina propria and of surface to crypt cell height. The ratio of goblet cells to epithelial cells also increased after treatment, while the numbers of polymorphs in the surface and crypt epithelium and lumen decreased. In conclusion, computerised morphometry is valuable for the assessment of the treatment of patients with ulcerative colitis and that in the doses used both treatments were of similar efficacy.

Full text

PDF
183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen D. C., Hamilton P. W., Watt P. C., Biggart J. D. Architectural morphometry in ulcerative colitis with dysplasia. Histopathology. 1988 Jun;12(6):611–621. doi: 10.1111/j.1365-2559.1988.tb01985.x. [DOI] [PubMed] [Google Scholar]
  2. Allen D. C., Hamilton P. W., Watt P. C., Biggart J. D. Morphometrical analysis in ulcerative colitis with dysplasia and carcinoma. Histopathology. 1987 Sep;11(9):913–926. doi: 10.1111/j.1365-2559.1987.tb01898.x. [DOI] [PubMed] [Google Scholar]
  3. Binder V. A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol. 1970;5(7):627–632. [PubMed] [Google Scholar]
  4. Brown L. J., Smeeton N. C., Dixon M. F. Assessment of dysplasia in colorectal adenomas: an observer variation and morphometric study. J Clin Pathol. 1985 Feb;38(2):174–179. doi: 10.1136/jcp.38.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Danielsson A., Hellers G., Lyrenäs E., Löfberg R., Nilsson A., Olsson O., Olsson S. A., Persson T., Salde L., Naesdal J. A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand J Gastroenterol. 1987 Oct;22(8):987–992. doi: 10.3109/00365528708991947. [DOI] [PubMed] [Google Scholar]
  6. Florén C. H., Benoni C., Willén R. Histologic and colonoscopic assessment of disease extension in ulcerative colitis. Scand J Gastroenterol. 1987 May;22(4):459–462. doi: 10.3109/00365528708991491. [DOI] [PubMed] [Google Scholar]
  7. Franklin W. A., McDonald G. B., Stein H. O., Gatter K. C., Jewell D. P., Clarke L. C., Mason D. Y. Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum Pathol. 1985 Nov;16(11):1129–1132. doi: 10.1016/s0046-8177(85)80181-7. [DOI] [PubMed] [Google Scholar]
  8. Graham A. R., Paplanus S. H., Bartels P. H. Micromorphometry of colonic lesions. Lab Invest. 1988 Sep;59(3):397–402. [PubMed] [Google Scholar]
  9. Hamilton P. W., Allen D. C., Watt P. C., Patterson C. C., Biggart J. D. Classification of normal colorectal mucosa and adenocarcinoma by morphometry. Histopathology. 1987 Sep;11(9):901–911. doi: 10.1111/j.1365-2559.1987.tb01897.x. [DOI] [PubMed] [Google Scholar]
  10. Jenkins D., Goodall A., Drew K., Scott B. B. What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol. 1988 Jan;41(1):72–79. doi: 10.1136/jcp.41.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mulder C. J., Tytgat G. N., Wiltink E. H., Houthoff H. J. Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial. Scand J Gastroenterol. 1988 Oct;23(8):1005–1008. doi: 10.3109/00365528809090161. [DOI] [PubMed] [Google Scholar]
  12. Powell-Tuck J., Day D. W., Buckell N. A., Wadsworth J., Lennard-Jones J. E. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci. 1982 Jun;27(6):533–537. doi: 10.1007/BF01296733. [DOI] [PubMed] [Google Scholar]
  13. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989 Jan 14;298(6666):82–86. doi: 10.1136/bmj.298.6666.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Riley S. A., Mani V., Goodman M. J., Herd M. E., Dutt S., Turnberg L. A. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology. 1988 Jun;94(6):1383–1389. doi: 10.1016/0016-5085(88)90677-4. [DOI] [PubMed] [Google Scholar]
  15. Rubio C. A., Johansson C., Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. II. Normal limits in symptomatic patients. Scand J Gastroenterol. 1982 Nov;17(8):1077–1081. [PubMed] [Google Scholar]
  16. Rubio C. A., Johansson C., Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. III. Chronic ulcerative colitis. Scand J Gastroenterol. 1982 Nov;17(8):1083–1087. [PubMed] [Google Scholar]
  17. Rubio C. A., Johansson C., Uribe A., Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. IV. Ulcerative colitis in remission. Scand J Gastroenterol. 1984 Jun;19(4):525–530. [PubMed] [Google Scholar]
  18. Thompson E. M., Price A. B., Altman D. G., Sowter C., Slavin G. Quantitation in inflammatory bowel disease using computerised interactive image analysis. J Clin Pathol. 1985 Jun;38(6):631–638. doi: 10.1136/jcp.38.6.631. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES